Clinicor Launches CorDat@ - an Innovative Internet Service for Conducting Clinical Trials.BALTIMORE Baltimore, city (1990 pop. 736,014), N central Md., surrounded by but politically independent of Baltimore co., on the Patapsco River estuary, an arm of Chesapeake Bay; inc. 1745. and AUSTIN, Texas--(BUSINESS WIRE)--June 28, 1999-- Clinicor, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:CLCR), an innovative provider of clinical research services to the pharmaceutical, biotechnology and medical device industries, launched CorDat@, its new proprietary, web-enabled enterprise application solution for accessing real-time 1. real-time - Describes an application which requires a program to respond to stimuli within some small upper limit of response time (typically milli- or microseconds). Process control at a chemical plant is the classic example. updates on clinical research trials in progress, at the 1999 Annual Meeting of the Drug Industry Association (DIA) June 27-30 in Baltimore, Maryland "Baltimore" redirects here. For the surrounding county, see Baltimore County, Maryland. For other uses, see Baltimore (disambiguation). Baltimore is an independent city located in the state of Maryland in the United States. . CorDat@ is an integral part of every new Clinicor study, allowing product development trial sponsors to log onto a secure extranet and view "real-time" project updates on patient enrollment, project management, clinical data management and financial project status, including investigator payments. This clinical trial management information system and its software tools are Y2K compliant Capable of correctly processing any data that deals with a date beyond the year 1999. See Y2K problem. . CorDat@ operates on a single database platform accessible through a secured website. Clinicor President, Robert S Robert, Henry Martyn 1837-1923. American army engineer and parliamentary authority. He designed the defenses for Washington, D.C., during the Civil War and later wrote Robert's Rules of Order (1876). Noun 1. . Sammis commented, "CorDat@ represents a significant investment to enhance our information technology capabilities. Sponsors have told us they are interested in having access to information tools like CorDat@ to allow them to efficiently monitor the progress of their clinical trials in "real-time." We expect to increase new business opportunities and revenues as we customize and continue to add new technologies and service offerings. CorDat@ gives our clients the control they want over their clinical trials, and the power to quickly identify any issues in order to implement proactive solutions immediately." Clinicor, Inc., an Austin, Texas-based contract research organization (CRO), provides clinical development services including Phase I - IV clinical trials management, patient recruitment, monitoring, data management services and regulatory consultation to the pharmaceutical, biotechnology and medical device industries. Clinicor differentiates itself through a unique operating model Operating Model is a term that is used in many contexts. In essence an operating model describes how an organization operates across both business and technology domains. The Operating Model describes what is important for the organization. that emphasizes its specialized spe·cial·ize v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es v.intr. 1. To pursue a special activity, occupation, or field of study. 2. patient recruitment, patient management and study monitoring capabilities. Management believes that Clinicor's approach accelerates the recruitment of patient populations and enhances the accuracy of clinical data, resulting in high caliber clinical trial services offering significant value to sponsors. Additional information is available at http://www.clinicor.com. Certain statements in this press release are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . A variety of factors could cause the Company's actual results and experience to differ materially from the results anticipated by management. Among the risks and uncertainties that could affect the Company's operations and performance are matters affecting the timing of clinical trials being conducted by the Company, including possible decisions by sponsors to suspend or alter the timing or scope of clinical trials, risks related to the management and financing of growth, and other risks. Detailed information concerning factors that could cause actual results to differ materially from management's expectations is available in the "Risk Factors" section of the Company's report on Form 10-KSB for the year ended December 31, 1998. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion